{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:31:50Z","timestamp":1779114710557,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,23]]},"DOI":"10.7759\/cureus.86617","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T21:55:23Z","timestamp":1750715723000},"source":"Crossref","is-referenced-by-count":3,"title":["Comparative Efficacy and Long-Term Outcomes of Drug-Eluting Stents vs. Bare-Metal Stents in Coronary Artery Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Hina","family":"Amjad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehtab","family":"Shakoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiqa","family":"Tanveer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehak","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazeelat","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamna","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed H","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fathima","family":"Masharifa Ahamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anik","family":"Halder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimsha","family":"Dilawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouman","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth GA","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, et al.. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020, 76:2982-3021. 10.1016\/j.jacc.2020.11.010","journal-title":"J Am Coll Cardiol"},{"key":"ref2","article-title":"Risk factors for coronary artery disease","author":"Brown JC","year":"2023","unstructured":"Brown JC, Gerhardt TE, Kwon E. Risk factors for coronary artery disease. StatPearls . StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.006363","article-title":"Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized controlled trials","volume":"13","author":"Chacko L","year":"2020","unstructured":"Chacko L, P Howard J, Rajkumar C, et al.. Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2020, 13:e006363. 10.1161\/CIRCOUTCOMES.119.006363","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.118.007023","article-title":"Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review","volume":"12","author":"Shlofmitz E","year":"2019","unstructured":"Shlofmitz E, Iantorno M, Waksman R. Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review. Circ Cardiovasc Interv. 2019, 12:e007023. 10.1161\/CIRCINTERVENTIONS.118.007023","journal-title":"Circ Cardiovasc Interv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-015-0393-y","article-title":"Bare metal stents versus drug-eluting stents: where do we stand in 2015?","volume":"17","author":"Meraj PM","year":"2015","unstructured":"Meraj PM, Jauhar R, Singh A. Bare metal stents versus drug-eluting stents: where do we stand in 2015?. Curr Treat Options Cardiovasc Med. 2015, 17:393. 10.1007\/s11936-015-0393-y","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini GG","year":"2013","unstructured":"Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med. 2013, 368:254-65. 10.1056\/NEJMra1210816","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008226","article-title":"Bleeding risk, dual antiplatelet therapy cessation, and adverse events after percutaneous coronary intervention: the Paris Registry","volume":"13","author":"Sorrentino S","year":"2020","unstructured":"Sorrentino S, Sartori S, Baber U, et al.. Bleeding risk, dual antiplatelet therapy cessation, and adverse events after percutaneous coronary intervention: the Paris Registry. Circ Cardiovasc Interv. 2020, 13:e008226. 10.1161\/CIRCINTERVENTIONS.119.008226","journal-title":"Circ Cardiovasc Interv"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.05.017","article-title":"Coronary in-stent restenosis: JACC state-of-the-art review","volume":"80","author":"Giustino G","year":"2022","unstructured":"Giustino G, Colombo A, Camaj A, et al.. Coronary in-stent restenosis: JACC state-of-the-art review. J Am Coll Cardiol. 2022, 80:348-72. 10.1016\/j.jacc.2022.05.017","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore S","year":"2012","unstructured":"Bangalore S, Kumar S, Fusaro M, et al.. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012, 125:2873-91. 10.1161\/CIRCULATIONAHA.112.097014","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20140110","article-title":"Efficacy and safety of drug-eluting stents in the real world: 8-year follow-up","volume":"103","author":"Pellegrini DO","year":"2014","unstructured":"Pellegrini DO, Gomes VO, Lasevitch R, et al.. Efficacy and safety of drug-eluting stents in the real world: 8-year follow-up. Arq Bras Cardiol. 2014, 103:174-82. 10.5935\/abc.20140110","journal-title":"Arq Bras Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati A","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009, 62:e1-34. 10.1016\/j.jclinepi.2009.06.006","journal-title":"J Clin Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184.ch8","article-title":"Assessing risk of bias in included studies","author":"Higgins JP","year":"2008","unstructured":"Higgins JP, Altman DG. Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Higgins JP, Green S (ed): John Wiley & Sons Ltd, Chichester; 2008. 187-241. 10.1002\/9780470712184.ch8"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang A","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010, 25:603-5. 10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.01.040","article-title":"Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis)","volume":"95","author":"Indolfi C","year":"2005","unstructured":"Indolfi C, Pavia M, Angelillo IF. Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). Am J Cardiol. 2005, 95:1146-52. 10.1016\/j.amjcard.2005.01.040","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021, 134:103-12. 10.1016\/j.jclinepi.2021.02.003","journal-title":"J Clin Epidemiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2020.07.018","article-title":"Drug-eluting stents versus bare-metal stents in large coronary artery revascularization: systematic review and meta-analysis","volume":"23","author":"Changal KH","year":"2021","unstructured":"Changal KH, Mir T, Khan S, et al.. Drug-eluting stents versus bare-metal stents in large coronary artery revascularization: systematic review and meta-analysis. Cardiovasc Revasc Med. 2021, 23:42-9. 10.1016\/j.carrev.2020.07.018","journal-title":"Cardiovasc Revasc Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30474-X","article-title":"Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials","volume":"393","author":"Piccolo R","year":"2019","unstructured":"Piccolo R, Bonaa KH, Efthimiou O, et al.. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2019, 393:2503-10. 10.1016\/S0140-6736(19)30474-X","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000986","article-title":"Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials","volume":"6","author":"Bjerking LH","year":"2019","unstructured":"Bjerking LH, Hansen KW, S\u00f8rensen R, et al.. Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials. Open Heart. 2019, 6:e000986. 10.1136\/openhrt-2018-000986","journal-title":"Open Heart"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.29159","article-title":"Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease","volume":"97","author":"Lafont A","year":"2021","unstructured":"Lafont A, Sinnaeve PR, Cuisset T, et al.. Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease. Catheter Cardiovasc Interv. 2021, 97:E607-13. 10.1002\/ccd.29159","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.026","article-title":"10-year outcomes from a randomized trial of polymer-free versus durable polymer drug-eluting coronary stents","volume":"76","author":"Kufner S","year":"2020","unstructured":"Kufner S, Ernst M, Cassese S, et al.. 10-year outcomes from a randomized trial of polymer-free versus durable polymer drug-eluting coronary stents. J Am Coll Cardiol. 2020, 76:146-58. 10.1016\/j.jacc.2020.05.026","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017434","article-title":"Long-term results after drug-eluting versus bare-metal stent implantation in saphenous vein grafts: randomized controlled trial","volume":"9","author":"Fahrni G","year":"2020","unstructured":"Fahrni G, Farah A, Engstr\u00f8m T, et al.. Long-term results after drug-eluting versus bare-metal stent implantation in saphenous vein grafts: randomized controlled trial. J Am Heart Assoc. 2020, 9:e017434. 10.1161\/JAHA.120.017434","journal-title":"J Am Heart Assoc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/jcpc.jcpc_56_19","article-title":"One-year clinical outcomes of drug-eluting stents versus bare-metal stents in large coronary arteries","volume":"9","author":"Singhal R","year":"2020","unstructured":"Singhal R, Prajapati J, Patel I, Patel C, Sahoo S. One-year clinical outcomes of drug-eluting stents versus bare-metal stents in large coronary arteries. J Clin Prev Cardiol. 2020, 9:56-60. 10.4103\/jcpc.jcpc_56_19","journal-title":"J Clin Prev Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018828","article-title":"Drug-eluting or bare-metal stents for left anterior descending or left main coronary artery revascularization","volume":"10","author":"Piccolo R","year":"2021","unstructured":"Piccolo R, Bonaa KH, Efthimiou O, et al.. Drug-eluting or bare-metal stents for left anterior descending or left main coronary artery revascularization. J Am Heart Assoc. 2021, 10:e018828. 10.1161\/JAHA.120.018828","journal-title":"J Am Heart Assoc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2023.11.001","article-title":"Natural history of coronary stents: 14 year follow-up of drug eluting stents versus bare metal stents","volume":"75","author":"Walse RS","year":"2023","unstructured":"Walse RS, Mohanan Nair KK, Valaparambil A, Sasidharan B, Sivadasapillai H, Thulaseedharan JV. Natural history of coronary stents: 14 year follow-up of drug eluting stents versus bare metal stents. Indian Heart J. 2023, 75:457-61. 10.1016\/j.ihj.2023.11.001","journal-title":"Indian Heart J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8179849","article-title":"Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis after the treatment of drug-eluting stent or drug-eluting balloon: a systematic review and meta-analysis","volume":"2020","author":"Yang YX","year":"2020","unstructured":"Yang YX, Liu Y, Li CP, Lu PJ, Wang J, Gao J. Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis after the treatment of drug-eluting stent or drug-eluting balloon: a systematic review and meta-analysis. J Interv Cardiol. 2020, 2020:8179849. 10.1155\/2020\/8179849","journal-title":"J Interv Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.07.010","article-title":"Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis","volume":"195","author":"Sambola A","year":"2020","unstructured":"Sambola A, Rello P, Soriano T, et al.. Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis. Thromb Res. 2020, 195:128-35. 10.1016\/j.thromres.2020.07.010","journal-title":"Thromb Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.21608\/ijma.2020.35338.1145","article-title":"Comparison between bare-metal stents and drug-eluting stents in patients undergoing percutaneous coronary intervention","volume":"2","author":"Elsayed KR","year":"2020","unstructured":"Elsayed KR. Comparison between bare-metal stents and drug-eluting stents in patients undergoing percutaneous coronary intervention. Int J Med Arts. 2020, 2:786-92. 10.21608\/ijma.2020.35338.1145","journal-title":"Int J Med Arts"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2021.05.009","article-title":"Very long-term safety and effectiveness of drug-eluting or bare-metal stents for left main coronary disease","volume":"3","author":"Park H","year":"2021","unstructured":"Park H, Ahn JM, Kang DY, et al.. Very long-term safety and effectiveness of drug-eluting or bare-metal stents for left main coronary disease. CJC Open. 2021, 3:1199-206. 10.1016\/j.cjco.2021.05.009","journal-title":"CJC Open"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008024","article-title":"Long-term effect of ultrathin-strut versus thin-strut drug-eluting stents in patients with small vessel coronary artery disease undergoing percutaneous coronary intervention: a subgroup analysis of the BIOSCIENCE randomized trial","volume":"12","author":"Iglesias JF","year":"2019","unstructured":"Iglesias JF, Heg D, Roffi M, et al.. Long-term effect of ultrathin-strut versus thin-strut drug-eluting stents in patients with small vessel coronary artery disease undergoing percutaneous coronary intervention: a subgroup analysis of the BIOSCIENCE randomized trial. Circ Cardiovasc Interv. 2019, 12:e008024. 10.1161\/CIRCINTERVENTIONS.119.008024","journal-title":"Circ Cardiovasc Interv"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109071","article-title":"Individualized or uniform de-escalation strategies for antiplatelet therapy in acute coronary syndrome: a review of clinical trials with platelet function testing and genetic testing-based protocols","volume":"24","author":"El Abdallaoui OE","year":"2023","unstructured":"El Abdallaoui OE, Tornyos D, Luk\u00e1cs R, Szab\u00f3 D, Kom\u00f3csi A. Individualized or uniform de-escalation strategies for antiplatelet therapy in acute coronary syndrome: a review of clinical trials with platelet function testing and genetic testing-based protocols. Int J Mol Sci. 2023, 24:9071. 10.3390\/ijms24109071","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.019","article-title":"Ultrathin bioresorbable polymer sirolimus-eluting stents versus thin durable polymer everolimus-eluting stents","volume":"72","author":"Kandzari DE","year":"2018","unstructured":"Kandzari DE, Koolen JJ, Doros G, et al.. Ultrathin bioresorbable polymer sirolimus-eluting stents versus thin durable polymer everolimus-eluting stents. J Am Coll Cardiol. 2018, 72:3287-97. 10.1016\/j.jacc.2018.09.019","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038065","article-title":"Ten-year clinical outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease","volume":"139","author":"Kufner S","year":"2019","unstructured":"Kufner S, Joner M, Thannheimer A, et al.. Ten-year clinical outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease. Circulation. 2019, 139:325-33. 10.1161\/CIRCULATIONAHA.118.038065","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.11.012","article-title":"Suboptimal stent deployment is associated with subacute stent thrombosis: optical coherence tomography insights from a multicenter matched study. From the CLI Foundation investigators: the CLI-THRO study","volume":"169","author":"Prati F","year":"2015","unstructured":"Prati F, Kodama T, Romagnoli E, et al.. Suboptimal stent deployment is associated with subacute stent thrombosis: optical coherence tomography insights from a multicenter matched study. From the CLI Foundation investigators: the CLI-THRO study. Am Heart J. 2015, 169:249-56. 10.1016\/j.ahj.2014.11.012","journal-title":"Am Heart J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254941","article-title":"Incidence, predictors, and outcomes of DAPT non-compliance in planned vs. ad hoc PCI in chronic coronary syndrome","volume":"16","author":"Malik J","year":"2021","unstructured":"Malik J, Yousaf H, Abbasi W, Hameed N, Mohsin M, Shahid AW, Fatima M. Incidence, predictors, and outcomes of DAPT non-compliance in planned vs. ad hoc PCI in chronic coronary syndrome. PLoS One. 2021, 16:e0254941. 10.1371\/journal.pone.0254941","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2017.01.009","article-title":"Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large coronary vessel lesions","volume":"14","author":"Yin D","year":"2017","unstructured":"Yin D, Li J, Yang YJ, et al.. Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large coronary vessel lesions. J Geriatr Cardiol. 2017, 14:35-41. 10.11909\/j.issn.1671-5411.2017.01.009","journal-title":"J Geriatr Cardiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1177\/1933719110367829","article-title":"Gender differences in cardiovascular disease: hormonal and biochemical influences","volume":"17","author":"P\u00e9rez-L\u00f3pez FR","year":"2010","unstructured":"P\u00e9rez-L\u00f3pez FR, Larrad-Mur L, Kallen A, Chedraui P, Taylor HS. Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci. 2010, 17:511-31. 10.1177\/1933719110367829","journal-title":"Reprod Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/340921-comparative-efficacy-and-long-term-outcomes-of-drug-eluting-stents-vs-bare-metal-stents-in-coronary-artery-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T21:55:25Z","timestamp":1750715725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/340921-comparative-efficacy-and-long-term-outcomes-of-drug-eluting-stents-vs-bare-metal-stents-in-coronary-artery-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.86617","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}